Latinos Kick Buts: Mobile Engagement and Cessation Support for Latinos Who Smoke

April 4, 2023 updated by: Paula Cupertino, University of Rochester
Latino Kick Buts (LKB) is a smoking cessation treatment program available to Strong Memorial Hospital patients who smoke. LKB encompasses two integrated components: (1) a 12-week text messaging counseling program with interactive capabilities and (2) pharmacotherapy support (provision of nicotine replacement therapy at no cost). LKB utilization among Latinos who smoke remains minimal. This study aims to identify the types of text messages more effective in enrolling Latinos who smoke, identified in the electronic medical record, into LKB.

Study Overview

Study Type

Interventional

Enrollment (Actual)

2826

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • New York
      • Rochester, New York, United States, 14642
        • University of Rochester Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult Latinos who smoke and have received medical care at Strong Memorial Hospital/SHARP healthcare within the last year.
  • having smoking status recorded in the EMR

Exclusion Criteria:

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: One cycle-no monetary incentive
Message Design Participants will receive 3 messages per cycle that contain information on how to enroll in a cessation program.
Active Comparator: One cycle-fixed amount of incentive
Message Design Participants will receive 3 messages per cycle that contain information on how to enroll in a cessation program.
Participants will receive 3 messages per cycle that contain information on how to enroll in a cessation program. The introductory message will mention that participants will receive $5 if they enroll in the program or that they should look out for messages with a "$" sign at the beginning that will provide an incentive if they respond.
Active Comparator: One cycle-raffle as incentive
Message Design Participants will receive 3 messages per cycle that contain information on how to enroll in a cessation program.
The incentive message (indicated with a leading "$" sign) will invite participants to respond, and participants that do so will be included in a random drawing depending on the condition. The incentive message for the opportunity to win will contain a link to a website that provides full details of the timing of the drawing, the chances of winning, and when notification of winners will be made.
Active Comparator: 4 cycles- no monetary incentive
Participants will receive 3 messages per cycle that contain information on how to enroll in a cessation program.
Active Comparator: 4 cycles- fixed amount of incentive
Participants will receive 3 messages per cycle that contain information on how to enroll in a cessation program. The introductory message will mention that participants will receive $5 if they enroll in the program or that they should look out for messages with a "$" sign at the beginning that will provide an incentive if they respond.
Participants will receive 3 messages per cycle that contain information on how to enroll in a cessation program.
Active Comparator: 4 cycles- raffle as incentive
The incentive message (indicated with a leading "$" sign) will invite participants to respond, and participants that do so will be included in a random drawing depending on the condition. The incentive message for the opportunity to win will contain a link to a website that provides full details of the timing of the drawing, the chances of winning, and when notification of winners will be made.
Participants will receive 3 messages per cycle that contain information on how to enroll in a cessation program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Percentage of participant who enroll in cessation program
Time Frame: 16 weeks
16 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 27, 2022

Primary Completion (Actual)

March 25, 2023

Study Completion (Actual)

March 25, 2023

Study Registration Dates

First Submitted

December 16, 2022

First Submitted That Met QC Criteria

February 7, 2023

First Posted (Actual)

February 10, 2023

Study Record Updates

Last Update Posted (Actual)

April 6, 2023

Last Update Submitted That Met QC Criteria

April 4, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00007635
  • R42MD010318 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on One cycle

3
Subscribe